Approved by the FDA in July 2023, the first over-the-counter (OTC) daily oral contraceptive pill Opill (norgestrel) “could dramatically improve family planning” in the United
In women with type 1 or type 2 diabetes with menopausal symptoms, hormone therapy (HT) is “expected to have a neutral-to-beneficial impact on glucose regulation,”
In an update of its 2017 recommendation on screening for preeclampsia, the U.S. Preventive Services Task Force (USPSTF) supports screening for hypertensive disorders in pregnant
In a nationwide study of women of reproductive age in Denmark, NSAID use was positively associated with venous thromboembolism, researchers report, and the risk was
In a pair of phase 3 trials, the investigational antidepressant zuranolone was effective in treating postpartum depression and major depressive disorder in adults. An editorialist
The addition of oral piroxicam 40 mg with levonorgestrel increased the efficacy of emergency contraception (EC) in a study conducted in Hong Kong. When used
Rates of prolapse recurrence following native tissue surgical vaginal prolapse repair at 12 months were not improved by adjunctive perioperative vaginal estrogen application, researchers report.
“Contraception counseling and provision are vital components of comprehensive health care,” write authors of an In the Clinic review of contraception. “An unplanned pregnancy can
In an important reaffirmation of prior guidance, the U.S. Preventive Services Task Force (USPSTF) “recommends that all persons planning to or who could become pregnant
Live birth rates were not improved when prednisone was used daily from the time endometrial preparation for frozen-thawed embryo transfer through early pregnancy, a placebo-controlled
